Hamden, CT, United States of America

Catherine R Brennan




Average Co-Inventor Count = 13.3

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Hamden, CT (US) (2004)
  • Hamden, NC (US) (2007)
  • Milford, CT (US) (2002 - 2009)
  • Durham, NC (US) (2009 - 2012)

Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Catherine R Brennan

Introduction

Catherine R Brennan is a notable inventor based in Hamden, CT (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating hyper-proliferative disorders. With a total of 6 patents, her work has the potential to impact many lives.

Latest Patents

Catherine's latest patents include innovative pyrrolotriazine derivatives that are useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. These inventions relate to novel pyrrolotriazine compounds, pharmaceutical compositions containing such compounds, and their use for the prevention and/or treatment of these medical conditions. Her research focuses on the therapeutic applications of these compounds, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Catherine has worked with prominent organizations, including Bayer Pharmaceuticals Corporation and Bayer Corporation. Her experience in these companies has allowed her to develop her expertise and contribute to groundbreaking research in her field.

Collaborations

Catherine has collaborated with esteemed colleagues such as William Johnston Scott and Harold C E Kluender. These partnerships have further enriched her work and expanded the scope of her inventions.

Conclusion

Catherine R Brennan's innovative work in the pharmaceutical industry exemplifies her dedication to improving healthcare through her inventions. Her contributions continue to pave the way for advancements in the treatment of serious medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…